Company Updates

21st June 2016, ASX Announcement BPS Technology Half year Highlights Revenue of $25.1 million, exceeding prior corresponding period (H1FY15: $24.9 million) EBITDA of $4.7 million, up  4% (H1FY15: $4.5 million) Earnings per share of 6.0c, up 7.2% (HY15: 5.6c) Interim dividend of 2.0 cents per share unfranked declared New Sales Model resulted in 39% growth […]

21st June 2016, ASX Announcement UBI: Investment Highlights: Targeting the large and growing Point-of-Care Diagnostics market Fast growth in revenues based on sale of disposable test strips Validating the technology through partnering deals with LifeScan and Siemens Unique patent protected technology with low cost manufacturing Driving growth beyond the existing product platform via new product […]

21st June 2016, ASX Announcement Highlights: HPA demand for lithium-ion battery manufacture forecast to increase at 30% per year to 2025 Demand forecast to increase from ~1,000tpa in 2016 to ~15,000tpa in 2015 Equivalent to four (4) of Altech’s proposed HPA plants required to satisfy 2025 demand Electric vehicle manufacturers requiring lithium-ion batteries HPA coated […]

New dates added for Sydney, Melbourne and now Brisbane.  Legado invites you to attend an early comment forum with current and prospective investors. This session is to provide you with an opportunity to gain insight into specific deals in our pipeline and share with us your perspective on the opportunities in front of us. There are […]

20th June 2016, ASX Announcement Cyber-security specialist Tesserent Limited (ASX:TNT) has appointed Kurt Hansen as Global Head of Sales. Kurt has been brought on board to grow Tesserent’s local and international Security-as-a-Service business. Kurt, whose career in the IT industry spans more than 20 years, has a proven track record of transforming sales teams and […]

Attached is the company’s new presentation detailing our proprietary Glycell™ process, the market opportunities for the process and projects we are currently developing.

16th June 2016, ASX Announcement Highlights GlaxoSmithKline (GSK) Australia extends its services agreement with MedAdvisor for a further 12 months. GSK will continue utilising MedAdvisor’s medication management platform to provide relevant information for patients prescribed three medicines within GSK Australia’s respiratory portfolio. Agreement will generate Patient Engagement Program (PEP), formerly knows as Medication Training and […]

Today’s featured business is ‘Project Solution’.  A fast emerging niche service company. Project Solution is an award winning business perfectly positioned to take advantage of the digital office revolution involving the majority of businesses from all industries. This award winning business’ management team have been in place in excess of 10 years and have been heavily involved […]

14th June 2016 , DeClout Limited The board of directors (the “Board” or “Directors”) of DeClout Limited (the “Company”, and together with its subsidiaries, the “Group”) refers to the Company’s announcement dated 4 June 2016 on the proposed increase in shareholding in an associated company to a subsidiary (“First Announcement”). Unless otherwise defined herein, all […]